loratadine
英
美
网络 氯雷他定; 氯雷他定片; 开瑞坦; 氯雷他啶; 氯雷他定胶囊
双语例句
- Efficacy and Safety of Mizolastine Sustained Release Tablets Comparison with Loratadine Tablets in Patients with Urticaria;
目的比较咪唑斯汀缓释片与氯雷他定片治疗荨麻疹的有效性与安全性。 - Objective: to evaluate the clinical effect of polysaccharide nucleic acid of BCG and loratadine in the combination in the treatment of chronic urticaria.
目的：观察卡介菌多糖核酸注射液联合氯雷他定治疗慢性荨麻疹的疗效。 - Studies on the Synthesis of Piperidine Intermediates and New Loratadine Analogues
新氯雷他定类似物及其哌啶类中间体的合成研究 - Respiratory alkalosis may be associated with loratadine overdosage and patients should be monitored for this complication.
呼吸性碱中毒可能超剂量的氯雷他定有关，应当注意病人的这种并发症。 - Preparation and in Vitro Release Test of Complex Loratadine Sustained Release Capsules
复方氯雷他定缓释胶囊的制备与体外释放度实验 - The UV spectrophotometry for determination of Loratadine dispersible tablets has been developed.
介绍了紫外分光光度法测定氯雷他定分散片的含量。 - GC/ MS analysis method of research for loratadine
氯雷他定的GC/MS分析方法研究 - Film Coating of Paracetamol, Loratadine and Pseudoephedrine Sulfate Sustained Release Tablets; gold ( excl. gold clad with precious metal) cutting
氨酚氯雷伪麻缓释片的薄膜包衣工艺黄金（不包括用贵金属包层的黄金）切片 - The Contrast Study of Fluticasone and Loratadine in Treatment of Allergic Rhinitis
辅舒良与氯雷他定治疗变应性鼻炎的临床对比研究 - Maybe that's because Claritin, known generically as loratadine, lost patent protection a while back and had sales of less than$ 800 million last year, down from the year before.
可能是因为划属于氯雷他定的克敏能在前阵子失去了专利保护，去年的销售额低于8亿美元，比前年要低。 - Determination of two components in compound loratadine sustained-release capsules by HPLC
HPLC法同时测定复方氯雷他定缓释胶囊中两组分含量 - AIM To develop a sensitive and specific method for the determination of loratadine in human plasma by LC-MS.
目的本文建立了专属、灵敏的液质联用方法，用于人血浆中氯雷他定浓度的测定。 - Objective To evaluate the clinical effectiveness and safety of compound loratadine capsule in the treatment of allergic rhinitis.
目的评价复方氯雷他定缓释胶囊治疗变应性鼻炎的有效性和安全性。 - Objective To evaluate the efficacy and safety of azelastine hydrochloride tablet in allergic rhinitis in compare with loratadine.
目的与对照药氯雷他定片比较，评价盐酸氮（？）斯汀片治疗变应性鼻炎的临床疗效及安全性。 - Bioequivalence of domestic loratadine tablets in healthy volunteers by HPLC/ MS
HPLC/MS法研究国产氯雷他定片的人体生物等效性 - Randomized Controlled Trial of Compound Loratadine Capsule in the Treatment of Allergic Rhinitis
复方氯雷他定缓释胶囊治疗变应性鼻炎的随机对照试验 - Determination of Loratadine Tablets and Its Related Substances by HPLC
氯雷他定片含量及有关物质的HPLC测定 - Conclusions Loratadine is still the first choice therapy of allergic reaction.
结论新一代抗组胺药氯雷他定目前仍是我院治疗过敏性疾病的首选药物。 - CONCLUSION: 2 loratadine tablets were bioequivalent.
结论：2种氯雷他定片具有生物等效性。 - Preparation and Quality Control of Loratadine Tablets
氯雷他定片的制备及质量控制 - Conclusion Loratadine and ketotifen can inhibit the exercise-induced bronchoconstriction in guinea pigs pretreated with LPS and metyrapone.
结论在用脂多糖和甲吡丙酮预处理的运动性哮喘豚鼠模型中，氯雷他定和酮替芬能够抑制支气管收缩。 - Structure Analysis of Loratadine
氯雷他定的结构分析 - Comparative study on the inhibitory action of mizolastine, loratadine and cetirizine in murine allergic contact dermatitis
咪唑斯汀、氯雷他定及西替利嗪对小鼠变应性接触性皮炎作用的比较研究 - A new HPLC MS method to determine loratadine in human plasma was established.
本文首次建立了测定人血浆中氯雷他定的液质联用方法。 - Study of Pharmacokinetics and Relative Bioavailability of Loratadine Tablets by HPLC-MS Method
HPLC-MS法研究氯雷他定片人体相对生物利用度及药代动力学 - Results Arachidonic acid-induced ear edema was reduced by mizolastine, but loratadine and cetirizine were not.
结果咪唑斯汀可抑制花生四烯酸诱导的小鼠耳部水肿，但氯雷他定和西替利嗪均不能； - OBJECTIVE To develop a column-switching HPLC method for determination of Loratadine in human plasma and to study the bioequivalence of Loratadine tabletes, capsules in 23 healthy volunteers.
目的建立测定人血浆中氯雷他定浓度的方法，研究氯雷他定的片剂及胶囊在人体内的相对生物利用度。 - Difference between each group: mizolastine group is more effective than loratadine group and chlortrimeton group.
各组鼠左耳诱发皮炎前后24小时厚度差的比较：咪哩斯汀组作用强于氯雷他定和扑尔敏；氯雷他定和扑尔敏无差别。 - Relative Bioavailability of 2 Products of Loratadine Tablets in Human Body
2种氯雷他定片剂的人体相对生物利用度试验 - To establish HPLC method for testing the related substance of Loratadine and its Preparation ( tablets, capsule, granules).
目的：采用HPLC法检查氯雷他定及其制剂（片剂、胶囊、颗粒剂）的有关物质。